Khaw P T, Migdal C S
Glaucoma Unit, Moorfields Eye Hospital London, UK.
Curr Opin Ophthalmol. 1996 Apr;7(2):24-33. doi: 10.1097/00055735-199604000-00005.
The wound healing response is the single most important determinant of the final intraocular pressure after glaucoma surgery. The use of antiscarring agents, particularly the antimetabolites 5-fluorouracil and mitomycin C, have revolutionized glaucoma surgery over the past decade. This subject has become more important with the realization that simply lowering the intraocular pressure to below 21 mm Hg is inadequate, and that optimal lowering of the intraocular pressure should be achieved in all patients undergoing surgery for glaucoma. However, the antimetabolites still have many potential problems and side effects, some of which are potentially sightthreatening. This review concentrates on the recent publications in this field that have determined the current "state of the art," with a view toward optimizing results and minimizing side effects for our patients with glaucoma in this exciting and challenging area of progress.
伤口愈合反应是青光眼手术后最终眼压的最重要单一决定因素。在过去十年中,抗瘢痕形成药物的使用,尤其是抗代谢药物5-氟尿嘧啶和丝裂霉素C,彻底改变了青光眼手术。随着人们认识到仅仅将眼压降至21 mmHg以下是不够的,并且在所有接受青光眼手术的患者中都应实现眼压的最佳降低,这个问题变得更加重要。然而,抗代谢药物仍然存在许多潜在问题和副作用,其中一些可能威胁视力。本综述集中于该领域最近的出版物,这些出版物确定了当前的“技术水平”,以期在这个令人兴奋且具有挑战性的进展领域中优化结果并将我们青光眼患者的副作用降至最低。